Literature DB >> 31309758

[PET/CT imaging manifestations of different pathological subtypes of liposarcoma].

Jianlan Fu1, Fahuan Song1, Aiping Cheng1.   

Abstract

OBJECTIVE: To analyze PET/CT imaging manifestations of different pathological subtypes of liposarcoma.
METHODS: The 18F-fluorodeoxyglucose(FDG) PET/CT features of 13 patients pathologically confirmed as liposarcoma were retrospectively reviewed. The metabolism degree and distribution of different subtypes of liposarcoma were compared.
RESULTS: The well-differentiated liposarcoma showed fat density mass with septa and irregular strip with mild FDG uptake. The myxoid liposarcoma showed cystic or cystic solid mass, single or multiple with mild-moderate FDG uptake heterogeneously or homogeneously. The dedifferentiated liposarcoma showed mixed soft tissue mass with high FDG uptake heterogeneously, larger lesion with necrosis centrally. The mixed type contained well differentiated type and dedifferentiated type, and showed multiple lesion with combined imaging manifestations. There were local invasions in 12 cases, no lymph node matastasis, and the recurrence of dedifferentiated liposarcoma with lung metastasis in 1 case. The maximum standard values (SUVmax) of FNCCLE grade G1, G2 and G3 liposarcoma were 3.00, 5.67 and 10.33, respectively; there was significant difference between G1 and G3 groups, G2 and G3 groups (all P<0.05).
CONCLUSIONS: PET/CT manifestations of liposarcoma of various pathological subtypes are different. Preoperative PET/CT examination can clarify the pathological types, scope of tumor invasion and metastasis of liposarcoma, which provides more information for clinical decision-making and is helpful for the preparation of surgical plan.

Entities:  

Mesh:

Year:  2019        PMID: 31309758      PMCID: PMC8800708          DOI: 10.3785/j.issn.1008-9292.2019.04.11

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  8 in total

1.  [New WHO classification of tumours of soft tissue and bone].

Authors:  Jean-Michel Coindre
Journal:  Ann Pathol       Date:  2012-10-12       Impact factor: 0.407

2.  Risk assessment in liposarcoma patients based on FDG PET imaging.

Authors:  Winfried Brenner; Janet F Eary; Willy Hwang; Cheryl Vernon; Ernest U Conrad
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-11       Impact factor: 9.236

3.  18F-FDG PET/CT and MRI features of myxoid liposarcomas and intramuscular myxomas.

Authors:  Brendan W Lunn; Laurel A Littrell; Doris E Wenger; Stephen M Broski
Journal:  Skeletal Radiol       Date:  2018-06-20       Impact factor: 2.199

Review 4.  Well-differentiated liposarcoma/atypical lipomatous tumor of the oral cavity: report of three cases and review of the literature.

Authors:  Evangelia Piperi; Konstantinos I Tosios; Nikolaos G Nikitakis; Vasileios F Kyriakopoulos; Fotios Tzerbos; Ioannis G Koutlas; Alexandra Sklavounou
Journal:  Head Neck Pathol       Date:  2012-01-11

5.  [The role of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in liposarcoma of the chest wall].

Authors:  Haruchika Yamamoto; Seiichiro Sugimoto; Kentaroh Miyoshi; Hiromasa Yamamoto; Junichi Soh; Masaomi Yamane; Shinichi Toyooka; Takahiro Oto; Shinichiro Miyoshi
Journal:  Kyobu Geka       Date:  2014-01

Review 6.  Complete response of a recurrent-metastatic liposarcoma with dedifferentiated histological features following the administration of trabectedin and review of literature.

Authors:  Tulay Kus; Gokmen Aktas; Mehmet Emin Kalender; Ediz Tutar; Esra Ulker; Celaletdin Camci
Journal:  J Cancer Res Ther       Date:  2015 Oct-Dec       Impact factor: 1.805

Review 7.  Surgery for Abdominal Well-Differentiated Liposarcoma.

Authors:  Sara A Mansfield; Raphael E Pollock; Valerie P Grignol
Journal:  Curr Treat Options Oncol       Date:  2018-01-16

8.  A case of dedifferentiated liposarcoma showing a biphasic pattern on 2-deoxy-2-f(18)-fluoro-d-glucose positron emission tomography/computed tomography.

Authors:  Manabu Hoshi; Naoto Oebisu; Jun Takada; Kenichi Wakasa; Hiroaki Nakamura
Journal:  Rare Tumors       Date:  2013-06-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.